ESCRS - Meibomian Gland Dysfunction: Diagnosis, treatment, case management decisions

Meibomian Gland Dysfunction: Diagnosis, treatment, case management decisions

Meibomian Gland Dysfunction: Diagnosis, treatment, case management decisions

In this supplement, published by EuroTimes in association with the ESCRS Education Forum, experts share their perspectives on optimizing MGD diagnosis and treatment. The supplement includes insights from José M. Benitez del Castillo, Spain; José L. Güell, Spain; Francesco Carones, Italy; Jesper Hjortdal, Denmark; Béatrice Cochener-Lamard, France; and David Touboul, France. The supplement is supported by an unrestricted medical educational grant from Alcon, Johnson & Johnson Vision and Novartis. Download Supplement - click here

Latest Articles

Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.